Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral SCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
JAMA Oncol 2020 Aug 27;[EPub Ahead of Print], JD Schoenfeld, GJ Hanna, VY Jo, B Rawal, YH Chen, PS Catalano, A Lako, Z Ciantra, JL Weirather, S Criscitiello, A Luoma, N Chau, J Lorch, JI Kass, D Annino, L Goguen, A Desai, B Ross, HJ Shah, HA Jacene, DN Margalit, RB Tishler, KW Wucherpfennig, SJ Rodig, R Uppaluri, RI HaddadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.